The cellular apoptosis susceptibility (CAS) protein is highly expressed in various cancers including melanomas, lymphomas, breast cancers, hepatomas, ovarian carcinomas, endometrial carcinomas, and colorectal cancers [1-8]. This evidence concerns the gene CSE1L and hepatocellular carcinoma.